A clinical trial evaluating the effect of caffeine, which has nonselective PDE inhibitory properties and is widely used in neonatal intensive care units for preventing apnea of prematurity, induced a significant weight gain reduction in these infants, although the difference was no longer present at two years of life [39], [40]. The gene discussed is ALDH7A1; the disease is Apnea.